{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:35:17Z","timestamp":1790789717194,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"CancerFree KIDS Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Diffuse intrinsic pontine glioma (DIPG) is a pediatric lethal high-grade brainstem glioma with no effective therapies. OLIG2 (oligodendrocyte transcription factor 2) was reported to be critical for the growth of a DIPG cell line CCHMC-DIPG-1. Surprisingly, we found that the CCHMC-DIPG-1 cells express little OLIG2 and exhibit a mesenchymal phenotype, which raised a question regarding the role of OLIG2 in the growth of DIPG cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated the function of OLIG2 in different DIPG cell lines through molecular and genetic approaches and performed transcriptomic and genomic landscape profiling including whole-genome bisulfite sequencing, RNA-seq, ATAC-seq, and ChIP-seq. shRNA-mediated knockdown and CRISPR-Cas9-mediated knockout approaches were utilized to assess OLIG2 functions in DIPG cell growth.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that DIPG cells are phenotypically heterogeneous and exhibit the characteristics of distinct malignant gliomas including proneural, classical, and mesenchymal subtypes. OLIG2 knockdown did not impact the growth of CCHMC-DIPG-1 cells, wherein OLIG2 is epigenetically silenced. Moreover, OLIG2 deletion did not substantially impair OLIG2-expressing proneural-like DIPG growth but led to an upregulation of HIPPO-YAP1 and epidermal growth factor receptor (EGFR) signaling and a tumor phenotype shift. Targeting HIPPO-YAP1 and EGFR signaling in OLIG2-deficient DIPG cells inhibited tumor cell growth.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data indicate that OLIG2 is dispensable for DIPG growth but regulates the phenotypic switch of DIPG tumor cells. OLIG2 downregulation leads to deregulation of adaptive YAP1 and EGFR signaling. Targeting YAP1 and EGFR pathways inhibits the growth of OLIG2-deficient DIPG cells, pointing to a therapeutic potential by targeting adaptive signaling to treat DIPG tumors with nominal OLIG2 expression.<\/jats:p><\/jats:sec>","DOI":"10.1093\/neuonc\/noab016","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T01:09:25Z","timestamp":1612314565000},"source":"Crossref","is-referenced-by-count":12,"title":["OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes"],"prefix":"10.1093","author":[{"given":"Yunfei","family":"Liao","sequence":"first","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaili","family":"Luo","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Deng","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Rao","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Xu","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Senthil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satarupa","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"DeWire-Schottmiller","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalen","family":"Berry","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Garrett","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Fouladi","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Drissi","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing Richard","family":"Lu","sequence":"additional","affiliation":[{"name":"Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"8","key":"2021032304464721300_CIT0001","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","article-title":"Advances toward an understanding of brainstem gliomas","volume":"24","author":"Donaldson","year":"2006","journal-title":"J Clin Oncol."},{"issue":"3","key":"2021032304464721300_CIT0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol."},{"issue":"3","key":"2021032304464721300_CIT0003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.23690","article-title":"Postnatal growth of the human pons: a morphometric and immunohistochemical analysis","volume":"523","author":"Tate","year":"2015","journal-title":"J Comp Neurol."},{"issue":"1","key":"2021032304464721300_CIT0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","article-title":"Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets","volume":"15","author":"Johung","year":"2017","journal-title":"Curr Neuropharmacol."},{"issue":"11","key":"2021032304464721300_CIT0005","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"2021032304464721300_CIT0006","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","article-title":"Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas","volume":"37","author":"Ballester","year":"2013","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"2021032304464721300_CIT0007","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell."},{"issue":"2","key":"2021032304464721300_CIT0008","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One."},{"issue":"8","key":"2021032304464721300_CIT0009","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol."},{"issue":"1","key":"2021032304464721300_CIT0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","article-title":"Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression","volume":"35","author":"Larson","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"2021032304464721300_CIT0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas","volume":"32","author":"Pathania","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2021032304464721300_CIT0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell."},{"issue":"10","key":"2021032304464721300_CIT0013","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/nor092","article-title":"Treatment of high-grade glioma in children and adolescents","volume":"13","author":"MacDonald","year":"2011","journal-title":"Neuro Oncol."},{"issue":"6190","key":"2021032304464721300_CIT0014","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science."},{"issue":"7628","key":"2021032304464721300_CIT0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature20123","article-title":"Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma","volume":"539","author":"Tirosh","year":"2016","journal-title":"Nature."},{"issue":"6332","key":"2021032304464721300_CIT0016","doi-asserted-by":"crossref","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","article-title":"Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq","volume":"355","author":"Venteicher","year":"2017","journal-title":"Science"},{"issue":"6386","key":"2021032304464721300_CIT0017","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science."},{"issue":"5","key":"2021032304464721300_CIT0018","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2021032304464721300_CIT0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0092-8674(02)00678-5","article-title":"Common developmental requirement for Olig function indicates a motor neuron\/oligodendrocyte connection","volume":"109","author":"Lu","year":"2002","journal-title":"Cell."},{"issue":"1","key":"2021032304464721300_CIT0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(02)00677-3","article-title":"The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification","volume":"109","author":"Zhou","year":"2002","journal-title":"Cell."},{"issue":"5","key":"2021032304464721300_CIT0021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2016.03.027","article-title":"Olig2-dependent reciprocal shift in PDGF and EGF receptor signaling regulates tumor phenotype and mitotic growth in malignant glioma","volume":"29","author":"Lu","year":"2016","journal-title":"Cancer Cell."},{"issue":"5","key":"2021032304464721300_CIT0022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2019.03.006","article-title":"Single-cell transcriptomics uncovers glial progenitor diversity and cell fate determinants during development and gliomagenesis","volume":"24","author":"Weng","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2021032304464721300_CIT0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"8","key":"2021032304464721300_CIT0024","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/neuonc\/now299","article-title":"The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas","volume":"19","author":"Anderson","year":"2017","journal-title":"Neuro Oncol."},{"issue":"7","key":"2021032304464721300_CIT0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med."},{"key":"2021032304464721300_CIT0026","doi-asserted-by":"crossref","first-page":"21.29.1","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr Protoc Mol Biol."},{"issue":"10","key":"2021032304464721300_CIT0027","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/gb-2012-13-10-r92","article-title":"Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling","volume":"13","author":"Boyle","year":"2012","journal-title":"Genome Biol."},{"issue":"8","key":"2021032304464721300_CIT0028","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","article-title":"Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells","volume":"24","author":"Vinci","year":"2018","journal-title":"Nat Med."},{"issue":"1\u20132","key":"2021032304464721300_CIT0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissi\u00e8re","year":"2008","journal-title":"Mutat Res."},{"key":"2021032304464721300_CIT0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.exphem.2017.07.009","article-title":"The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia","volume":"55","author":"Yalcin","year":"2017","journal-title":"Exp Hematol"},{"issue":"8","key":"2021032304464721300_CIT0031","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods."},{"issue":"2","key":"2021032304464721300_CIT0032","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell."},{"issue":"43","key":"2021032304464721300_CIT0033","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2021032304464721300_CIT0034","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suv\u00e0","year":"2014","journal-title":"Cell."},{"issue":"2","key":"2021032304464721300_CIT0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ccell.2018.01.005","article-title":"Programming of Schwann cells by Lats1\/2-TAZ\/YAP signaling drives malignant peripheral nerve sheath tumorigenesis","volume":"33","author":"Wu","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"2021032304464721300_CIT0036","doi-asserted-by":"crossref","first-page":"e1900162","DOI":"10.1002\/bies.201900162","article-title":"YAP\/TAZ: drivers of tumor growth, metastasis, and resistance to therapy","volume":"42","author":"Thompson","year":"2020","journal-title":"Bioessays."},{"issue":"2","key":"2021032304464721300_CIT0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.4282","article-title":"Using the molecular classification of glioblastoma to inform personalized treatment","volume":"232","author":"Olar","year":"2014","journal-title":"J Pathol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noab016\/36660441\/noab016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noab016\/36660441\/noab016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T23:18:34Z","timestamp":1619219914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article\/doi\/10.1093\/neuonc\/noab016\/6128721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noab016","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"article-number":"noab016"}}